Lilly Asia Ventures Invests In Millin, A China Hemodialysis Company

Lilly Asia Ventures has made an investment of undisclosed size in Millin Enterprises, a Beijing company specializing in medical devices and treatment for kidney disease. The funding was an A round for Millin, which claims to supply about 50% of the medical devices and supplies used in Beijing's 130 hemodialysis centers. The company also operates the Heilongjiang Sidley hospital that is dedicated to treating kidney disease. The hospital, which has 150 dialysis machines, opened in January 2015.